Back to TNXP
UBS Group AG TNXP Position History
Tonix Pharmaceuticals Holding Corp. • Healthcare
Quarters held
15
Latest value
$127K
Q3 2026
Peak value
$3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $2K |
| Q3 2025 | $923K |
| Q3 2025 | $246K |
| Q3 2025 | $75K |
| Q4 2025 | $1.2M |
| Q4 2025 | $188K |
| Q4 2025 | $297 |
| Q1 2026 | $3M |
| Q1 2026 | $154K |
| Q1 2026 | $22K |
| Q2 2026 | $2.8M |
| Q2 2026 | $166K |
| Q3 2026 | $4K |
| Q3 2026 | $1.4M |
| Q3 2026 | $127K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $127K | 13.0K | — | — |
| Q3 2026 | $1.4M | 139.6K | — | — |
| Q3 2026 | $4K | 421 | — | — |
| Q2 2026 | $166K | 13.0K | — | — |
| Q2 2026 | $2.8M | 218.7K | — | — |
| Q1 2026 | $22K | 1.6K | — | — |
| Q1 2026 | $154K | 11.2K | — | — |
| Q1 2026 | $3M | 218.8K | — | — |
| Q4 2025 | $297 | 19 | — | — |
| Q4 2025 | $188K | 12.0K | — | — |
| Q4 2025 | $1.2M | 79.4K | — | — |
| Q3 2025 | $75K | 3.1K | — | — |
| Q3 2025 | $246K | 10.2K | — | — |
| Q3 2025 | $923K | 38.2K | — | — |
| Q3 2025 | $2K | 68 | — | — |